Journal of Digestive Cancer Reports

Korean Society of Gastrointestinal Cancer Research (대한소화기암연구학회)
권호 표지
DOI QR코드

DOI QR Code

Recent Advance in the Management of Dysplasia in the Ulcerative Colitis

  • Yang, Dong-Hoon (Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2021.11.16
  • Accepted : 2021.11.17
  • Published : 2021.12.01
⟨ Previous Next ⟩

Abstract

In patients having long-standing ulcerative colitis (UC), the risk of colorectal cancer (CRC) increased compared with general population. Dysplasia is a precancerous lesion of colitic patients, and traditionally total proctocolectomy was considered as a standard therapy to prevent colorectal cancer in UC patients. However, even with ileal pouch-anal anastomosis (IPAA), patients who underwent total proctocolectomy may experience early and late postoperative complications, such as ileus, bleeding, pouchitis, and so on. In addition, the bowel movement after proctocolectomy with IPAA reaches a median of seven times per day, and a considerable proportion of patients require daytime and nighttime pads. Change in the strategy for managing dysplasia started from two early studies, which suggested polypectomy for polypoid dysplasia to prevent CRC in colitic patients. After that, many studies supported that polypectomy should be the first option for the management of polypoid dysplasia. Moreover, recent studies suggested the feasibility of endoscopic submucosal dissection as a therapeutic option for non-polypoid dysplasia, although long term, large studies should be followed.

Keywords

References

  1. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012;10:639-645. https://doi.org/10.1016/j.cgh.2012.01.010
  2. Colman RJ, Rubin DT. Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review. Intest Res 2016;14:202-210. https://doi.org/10.5217/ir.2016.14.3.202
  3. Zhiqin W, Palaniappan S, Raja Ali RA. Inflammatory bowel disease-related colorectal cancer in the Asia-Pacific region: past, present, and future. Intest Res 2014;12:194-204. https://doi.org/10.5217/ir.2014.12.3.194
  4. Velayos F, Kathpalia P, Finlayson E. Changing paradigms in detection of dysplasia and management of patients with inflammatory bowel disease: is colectomy still necessary? Gastroenterology 2017;152:440-450.e1. https://doi.org/10.1053/j.gastro.2016.10.006
  5. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999;117:1295-1300. https://doi.org/10.1016/S0016-5085(99)70279-9
  6. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999;117:1288-1294; discussion 1488-1491. https://doi.org/10.1016/S0016-5085(99)70278-7
  7. Wanders LK, Dekker E, Pullens B, Bassett P, Travis SP, East JE. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol 2014;12:756-764. https://doi.org/10.1016/j.cgh.2013.07.024
  8. Mohan BP, Khan SR, Chandan S, et al. Endoscopic resection of colon dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis. Gastrointest Endosc 2021;93:59-67.e10. https://doi.org/10.1016/j.gie.2020.06.048
  9. Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013;7:982-1018. https://doi.org/10.1016/j.crohns.2013.09.016
  10. Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015;148:639-651.e28. https://doi.org/10.1053/j.gastro.2015.01.031
  11. American Society for Gastrointestinal Endoscopy Standards of Practice Committee, Shergill AK, Lightdale JR, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc 2015;81:1101-1121.e1-e13. https://doi.org/10.1016/j.gie.2014.10.030
  12. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-968. https://doi.org/10.1016/s0046-8177(83)80175-0
  13. Langner C, Magro F, Driessen A, et al. The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch 2014;464:511-527. https://doi.org/10.1007/s00428-014-1543-4
  14. Vieth M, Neumann H. Current issues in inflammatory bowel disease neoplasia. Histopathology 2015;66:37-48. https://doi.org/10.1111/his.12565
  15. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:746-774, 774.e1-e4; quiz e12-e13. https://doi.org/10.1053/j.gastro.2009.12.035
  16. Choi CH, Rutter MD, Askari A, et al. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview. Am J Gastroenterol 2015;110:1022-1034. https://doi.org/10.1038/ajg.2015.65
  17. Choi CH, Ignjatovic-Wilson A, Askari A, et al. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer. Am J Gastroenterol 2015;110:1461-1471; quiz 1472. https://doi.org/10.1038/ajg.2015.248
  18. Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366-374. https://doi.org/10.1016/0016-5085(81)90727-7
  19. Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007;25:657-668. https://doi.org/10.1111/j.1365-2036.2007.03241.x
  20. Akiyama S, Rai V, Rubin DT. Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment. Intest Res 2021;19:1-11. https://doi.org/10.5217/ir.2020.00047
  21. Emoto S, Hata K, Nozawa H, et al. Risk factors for non-reaching of ileal pouch to the anus in laparoscopic restorative proctocolectomy with handsewn anastomosis for ulcerative colitis. Intest Res 2021. doi: 10.5217/ir.2020.00158. [Epub ahead of print]
  22. Lin CC, Wei SC, Lin BR, et al. A retrospective analysis of 20-year data of the surgical management of ulcerative colitis patients in Taiwan: a study of Taiwan Society of Inflammatory Bowel Disease. Intest Res 2016;14:248-257. https://doi.org/10.5217/ir.2016.14.3.248
  23. Yoon YS, Cho YB, Park KJ, et al. Surgical outcomes of Korean ulcerative colitis patients with and without colitis-associated cancer. World J Gastroenterol 2015;21:3547-3553. https://doi.org/10.3748/wjg.v21.i12.3547
  24. Peyrin-Biroulet L, Germain A, Patel AS, Lindsay JO. Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis. Aliment Pharmacol Ther 2016;44:807-816. https://doi.org/10.1111/apt.13763
  25. Fazio VW, Kiran RP, Remzi FH, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013;257:679-685. https://doi.org/10.1097/SLA.0b013e31827d99a2
  26. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143:844-857. https://doi.org/10.1053/j.gastro.2012.06.001
  27. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68(Suppl 3):s1-s106. https://doi.org/10.1136/gutjnl-2019-318484
  28. Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extraintestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis 2017;11:649-670. https://doi.org/10.1093/ecco-jcc/jjx008
  29. Iacopini F, Saito Y, Yamada M, et al. Curative endoscopic submucosal dissection of large nonpolypoid superficial neoplasms in ulcerative colitis (with videos). Gastrointest Endosc 2015;82:734-738. https://doi.org/10.1016/j.gie.2015.02.052
  30. Suzuki N, Toyonaga T, East JE. Endoscopic submucosal dissection of colitis-related dysplasia. Endoscopy 2017;49:1237-1242. https://doi.org/10.1055/s-0043-114410
  31. Kinoshita S, Uraoka T, Nishizawa T, et al. The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitis. Gastrointest Endosc 2018;87:1079-1084. https://doi.org/10.1016/j.gie.2017.10.035
  32. Yang DH, Kim J, Song EM, et al. Outcomes of ulcerative colitis-associated dysplasia patients referred for potential endoscopic submucosal dissection. J Gastroenterol Hepatol 2019;34:1581-1589. https://doi.org/10.1111/jgh.14623
  33. Manta R, Zullo A, Telesca DA, et al. Endoscopic submucosal dissection for visible dysplasia treatment in ulcerative colitis patients: cases series and systematic review of literature. J Crohns Colitis 2021;15:165-168. https://doi.org/10.1093/ecco-jcc/jjaa158
  34. Nishio M, Hirasawa K, Ozeki Y, et al. An endoscopic treatment strategy for superficial tumors in patients with ulcerative colitis. J Gastroenterol Hepatol 2021;36:498-506. https://doi.org/10.1111/jgh.15207
  35. Ferlitsch M, Moss A, Hassan C, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 2017;49:270-297. https://doi.org/10.1055/s-0043-102569
  36. Kaltenbach T, Anderson JC, Burke CA, et al. Endoscopic removal of colorectal lesions-recommendations by the US multi-society task force on colorectal cancer. Gastrointest Endosc 2020;91:486-519. https://doi.org/10.1016/j.gie.2020.01.029
  37. Saito Y, Otake Y, Sakamoto T, et al. Indications for and technical aspects of colorectal endoscopic submucosal dissection. Gut Liver 2013;7:263-269. https://doi.org/10.5009/gnl.2013.7.3.263
  38. Yang DH, Jeong GH, Song Y, et al. The feasibility of performing colorectal endoscopic submucosal dissection without previous experience in performing gastric endoscopic submucosal dissection. Dig Dis Sci 2015;60:3431-3441. https://doi.org/10.1007/s10620-015-3755-0
  39. Toyonaga T, Nishino E, Man-I M, East JE, Azuma T. Principles of quality controlled endoscopic submucosal dissection with appropriate dissection level and high quality resected specimen. Clin Endosc 2012;45:362-374. https://doi.org/10.5946/ce.2012.45.4.362
  40. Yang DH, Rey I. Endoscopic submucosal dissection for colitis-associated dysplasia. Clin Endosc 2019;52:120-128. https://doi.org/10.5946/ce.2019.047
  41. Bordillon P, Pioche M, Wallenhorst T, et al. Double-clip traction for colonic endoscopic submucosal dissection: a multicenter study of 599 consecutive cases (with video). Gastrointest Endosc 2021;94:333-343. https://doi.org/10.1016/j.gie.2021.01.036